Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-29

Clinical Trial Update: Combination Regimen With Sodium Valproate for Severe Hemophilia: a Single-arm, Phase 1, Pilot Trial. [Phase 1, Phase 2]

View source ↗

Summary

A single-arm Phase 1/2 pilot trial evaluating a combination regimen with sodium valproate for severe hemophilia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium valproate (valproate)

Snippet

Sponsor: Xue-chun Lu | Conditions: Hemophilia | Phase 1, Phase 2 | Status: UNKNOWN